EV/EBITDA:
158.81+4.11(+2.66%)Summary
- As of today, PTGX EV/EBITDA is 158.81, with a rise of +4.11 (+2.66%) during the most recent trading session on October 17, 2025.
- Over the past year, PTGX EV/EBITDA has increased by +143.44 (+933.25%).
- PTGX EV/EBITDA is now -12.18% below its all-time high of 180.83.
Performance
PTGX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
PTGX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +2.7% | +2.6% | +2.3% |
| 1M1 Month | +36.4% | +36.4% | +30.9% |
| 3M3 Months | +44.7% | +44.7% | +37.3% |
| 6M6 Months | +107.7% | +85.1% | +67.5% |
| YTDYTD | +1984.1% | +118.8% | +100.8% |
| 1Y1 Year | +933.3% | +82.1% | +64.8% |
| 5Y5 Years | +1699.3% | +623.4% | +272.2% |
PTGX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 180.83 | -12.2% | 116.43 | +36.4% |
| 3M | 3-Month | 180.83 | -12.2% | 97.29 | +63.2% |
| 6M | 6-Month | 180.83 | -12.2% | 67.75 | +134.4% |
| 1Y | 1-Year | 180.83 | -12.2% | 6.83 | +2225.2% |
| 3Y | 3-Year | 180.83 | -12.2% | -16.97 | +1035.8% |
| 5Y | 5-Year | 180.83 | -12.2% | -27.68 | +673.7% |
| All-Time | All-Time | 180.83 | -12.2% | -27.68 | +673.7% |
PTGX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 158.81(+1984.1%) |
| 2024 | 7.62(+170.0%) |
| 2023 | -10.88(-357.1%) |
| 2022 | -2.38(+77.7%) |
| 2021 | -10.69(-13.0%) |
| Date | Value |
|---|---|
| 2020 | -9.46(-836.6%) |
| 2019 | -1.01(-46.4%) |
| 2018 | -0.69(+91.4%) |
| 2017 | -8.06(+10.1%) |
| 2016 | -8.97 |
FAQ
- What is Protagonist Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?
- What is PTGX EV/EBITDA year-to-date change?
- What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?
What is Protagonist Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of PTGX is 158.81
What is the all-time high EV/EBITDA for Protagonist Therapeutics, Inc.?
Protagonist Therapeutics, Inc. all-time high EV/EBITDA is 180.83
What is PTGX EV/EBITDA year-to-date change?
Protagonist Therapeutics, Inc. EV/EBITDA has changed by +151.19 (+1984.12%) since the beginning of the year
What is Protagonist Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, PTGX EV/EBITDA has changed by +143.44 (+933.25%)